Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (3y) (2012 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | 1.02% |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | 15.11% |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 41.83% |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | -27.98% |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 1.02% |
| Mar 29, 2026 | 320.47% |
| Dec 28, 2025 | 24.10% |
| Mar 30, 2025 | 26.49% |
| Sep 29, 2024 | -11.77% |
| Jun 30, 2024 | -11.30% |
| Mar 31, 2024 | -21.33% |
| Dec 31, 2023 | 29.29% |
| Oct 1, 2023 | 89.29% |
| Jul 2, 2023 | 6.85% |
| Apr 2, 2023 | -26.20% |
| Jan 1, 2023 | -18.92% |
| Apr 3, 2022 | 5.14% |
| Oct 3, 2021 | -6.92% |
| Jul 4, 2021 | 11.17% |
| Apr 4, 2021 | 6.34% |
| Jan 3, 2021 | 28.82% |
| Sep 27, 2020 | -7.15% |
| Jun 28, 2020 | -6.94% |
| Mar 29, 2020 | 4.34% |